文献速递中医妇科中药与中成药合理使用

β-榄香烯经MAPK与STAT3通路诱导铁死亡抑制子宫内膜异位症

β-elemene, a sesquiterpene constituent from Curcuma phaeocaulis inhibits the development of endometriosis by inducing ferroptosis via the MAPK and STAT3 signaling pathways.
PubMed 文献 · J Ethnopharmacol · 2025-01-10

本研究结合网络药理学、生物信息学、表面等离子共振-高效液相色谱-质谱联用、分子对接及体内外实验,探究温莪术来源的β-榄香烯抗子宫内膜异位症机制;结果显示β-榄香烯可抑制异位子宫内膜细胞增殖与迁移、诱导铁死亡,并在小鼠模型中抑制病灶生长与纤维化。

要点

  • β-榄香烯可抑制子宫内膜异位症细胞增殖与迁移并诱导铁死亡。
  • 其作用与下调GPX4、FTH1、FTL及抑制STAT3、MAPK14磷酸化相关。
  • 小鼠模型中β-榄香烯可抑制异位病灶生长与纤维化。

核心结论

  • β-榄香烯通过MAPK与STAT3信号通路诱导铁死亡,从而在体内外抑制子宫内膜异位症。

研究设计与样本

  • 研究采用网络药理学与生物信息学预测靶点,并以SPR-HPLC-MS和分子对接进一步鉴定β-榄香烯的潜在靶点。
  • 体外实验使用永生化子宫内膜异位症上皮细胞系12Z。
  • 体内建立小鼠子宫内膜异位症模型,评估β-榄香烯及ELE注射液的抑制作用与用药安全性。

主要发现

  • SPR-HPLC-MS鉴定出β-榄香烯治疗子宫内膜异位症的76个潜在靶点,与铁死亡密切相关。
  • 分子对接显示GPX4、FTH1、FTL、STAT3与MAPK14为β-榄香烯的关键作用靶点。
  • 体外实验中β-榄香烯抑制异位子宫内膜细胞增殖与迁移并诱导铁死亡,表现为铁、活性氧与脂质过氧化水平升高。
  • 小鼠模型中β-榄香烯抑制异位病灶生长、诱导铁死亡并抑制纤维化。
  • 机制上β-榄香烯下调GPX4、FTH1、FTL表达并抑制STAT3与MAPK14磷酸化。

关键数值与推荐

  • SPR亲和分析用于明确β-榄香烯与FTH1、FTL、GPX4、STAT3及MAPK14的直接相互作用。
  • 铁死亡判定采用蛋白质印迹、免疫组化染色与流式细胞术。
  • 细胞增殖与迁移采用CCK-8、EdU与划痕愈合实验检测,超微结构变化采用透射电镜观察。

临床怎么用

  • 该研究为β-榄香烯作为子宫内膜异位症潜在治疗药物提供了实验依据,但尚需临床研究验证。
  • β-榄香烯的抗子宫内膜异位症作用与铁死亡诱导及MAPK、STAT3通路抑制相关,可作为后续机制研究方向。

局限性

  • 体外研究仅使用永生化子宫内膜异位症上皮细胞系12Z,未涵盖其他细胞类型。
  • 研究结果主要基于网络药理学预测、分子对接与动物模型,尚缺乏临床样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: The rhizome of Curcuma phaeocaulis Valeton, Curcuma wenyujin Y.H. Chen & C. Ling, or Curcuma kwangsiensis S. G. Lee et C. F. Liang, commonly known as Wen-E-Zhu and E'zhu, has been utilized in traditional Chinese medicine for the treatment of cancer and gynecological diseases since antiquity. This traditional medicinal herb is highly esteemed for its efficacy in promoting blood circulation, dissolving blood stasis, reducing swelling, and alleviating pain. β-Elemene (β-ELE), a sesquiterpene compound derived from Curcuma phaeocaulis, has demonstrated potential in inhibiting tumor cell proliferation and inducing ferroptosis, which have been extensively studied in various malignant neoplasms. Previous studies have confirmed that Sparganium stoloniferum-Curcuma phaeocaulis containing β-ELE may possess anti-endometriotic properties. However, the exact mechanism underlying β-ELE's anti-endometriosis activity remains largely unknown and requires further research and investigation. AIM OF THE STUDY: To identify the anti-endometriosis target of β-ELE and elucidate the underlying molecular mechanism of β-ELE in endometriosis, focusing on inducing ferroptosis. MATERIALS AND METHODS: The target pathway of β-ELE in endometriosis treatment was predicted through network pharmacology and bioinformatics analysis. Surface plasmon resonance-high performance liquid chromatography-protein mass spectrometry (SPR-HPLC-MS) and molecular docking were used to further identify the potential targets of β-ELE in endometriosis. The immortalized endometriosis epithelial cell line 12Z was used for in vitro study. The effect of β-ELE on cell proliferation and migration was detected by CCK-8, EdU and wound healing assay, and ultrastructural changes were examined via transmission electron microscopy. The effect of β-ELE-induced ferroptosis was determined by western blot, immunohistochemistry staining and flow cytometry. SPR affinity analysis was performed to specific the direct interaction between β-ELE and FTH1, FTL, GPX4, STAT3 and MAPK14. To establish a mouse model of endometriosis and to assess the inhibitory effects of β-ELE and ELE injection on endometriosis in vivo as well as safety profile of administration, and investigate the effects and underlying mechanisms of β-ELE and ELE injection on ferroptosis in ectopic lesions. RESULTS: SPR-HPLC-MS was employed to identify 76 potential targets of β-ELE for endometriosis treatment, closely linked to ferroptosis. Molecular docking revealed that glutathione peroxidase 4 (GPX4), ferritin heavy chain 1 (FTH1), ferritin light chain (FTL), signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein kinase 14 (MAPK14) are key action targets of β-ELE in endometriosis. Further investigations revealed that β-ELE inhibited the proliferation and migration of endometriotic cells in vitro while inducing ferroptosis, as evidenced by increased levels of iron, reactive oxygen species (ROS), and lipid peroxidation. In a mouse model, β-ELE inhibited the growth of endometriotic lesions, induced ferroptosis, suppressed fibrosis, and exhibited anti-endometriotic effects. Mechanistically, β-ELE downregulates the expression levels of GPX4, FTH1, and FTL and inhibited the phosphorylation of STAT3 and MAPK14, which may elucidate its underlying molecular mechanisms. CONCLUSION: This study demonstrates that the inhibitory effect of β-ELE on endometriosis by inducing ferroptosis in vitro and in vivo. Our results revealed that β-ELE exerts anti-endometriosis effects by inducing ferroptosis via the MAPK and STAT3 signaling pathways.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Fu Z, Liu H, Kuang Y, et al. β-elemene, a sesquiterpene constituent from Curcuma phaeocaulis inhibits the development of endometriosis by inducing ferroptosis via the MAPK and STAT3 signaling pathways. J Ethnopharmacol. 2025. PMID: 39800242. doi:10.1016/j.jep.2025.119344

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。